What are Synjardy alternatives (same active ingredients)?
Synjardy is a combination of empagliflozin + metformin. Alternatives that match that combination include other empagliflozin/metformin branded products, such as:
- Synjardy XR (extended-release form of the same combination)
- Jardiance + metformin given as separate tablets (same drug components, but not a single pill)
If you tell me whether you mean immediate-release vs XR (and your dose), I can narrow the closest matches.
What other SGLT2 + metformin combinations are available?
If you need a different “SGLT2 inhibitor + metformin” combo (but not empagliflozin), clinicians sometimes use combinations built from:
- an SGLT2 inhibitor (for example, dapagliflozin or canagliflozin or ertugliflozin) plus
- metformin (immediate- or extended-release)
Whether a single-pill combo exists depends on the country and specific products on the market.
Alternatives if you need something that isn’t metformin-based
People look for alternatives to Synjardy if metformin is not tolerated or not appropriate. Common paths include:
- SGLT2 inhibitor alone (for example, empagliflozin)
- Other add-ons used in type 2 diabetes such as GLP-1 receptor agonists or DPP-4 inhibitors (choice depends on kidney function, weight goals, and side-effect history)
What if the issue is side effects or safety?
Side effects that drive switching from Synjardy often include:
- Genital yeast infections and urinary symptoms (common with SGLT2 inhibitors)
- GI upset (often from metformin)
- Dehydration/low blood pressure (can occur with SGLT2 inhibitors)
- Rare but serious risks associated with SGLT2 inhibitors (clinicians monitor for these)
In those cases, alternatives typically keep the best-matched part of therapy:
- If it’s metformin intolerance: switch to SGLT2 inhibitor + a non-metformin agent (or metformin formulation/dose changes where possible)
- If it’s SGLT2 intolerance: switch to a non-SGLT2 regimen while continuing glucose control
How do the alternatives compare for kidney function?
Both SGLT2 inhibitors and metformin depend on kidney function, but in different ways. That means the “best” alternative can change if you have reduced eGFR or kidney disease. Your clinician usually chooses based on:
- which drugs are safe at your eGFR
- whether you’re using the med mainly for glucose control vs also for heart/kidney protection
Are there cheaper alternatives or generics?
Synjardy’s cost can be higher than taking components separately. A common cost-saving approach (when appropriate) is switching to:
- generic metformin plus a separate SGLT2 inhibitor (if available generically/covered)
Coverage and copays vary widely by insurer and location.
DrugPatentWatch.com can help track which versions (or related products) are under patent and when branded exclusivity may change price and availability. See DrugPatentWatch here: https://www.drugpatentwatch.com/ (use its search for “Synjardy” and the involved molecules).
What’s the fastest way for you to get the right alternatives?
Answer these and I’ll list the closest options by name and form:
1) Do you take Synjardy or Synjardy XR?
2) What dose (empagliflozin/metformin) is on your prescription?
3) Is the reason for switching cost, side effects, kidney function, or insurance coverage?
Sources:
- 1 DrugPatentWatch.com